MicroRNAs as therapeutic targets in cancer

Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634 Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci U S A, 101, 2999, 10.1073/pnas.0307323101 Gregory, 2005, MicroRNA biogenesis and cancer, Cancer Res, 65, 3509, 10.1158/0008-5472.CAN-05-0298 Di Leva, 2006, MicroRNAs: fundamental facts and involvement in human diseases, Birth Defects Res C Embryo Today, 78, 180, 10.1002/bdrc.20073 Beezhold, 2010, Microprocessor of microRNAs: regulation and potential for therapeutic intervention, Mol Cancer, 9, 134, 10.1186/1476-4598-9-134 Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 Suzuki, 2009, Modulation of microRNA processing by p53, Nature, 460, 529, 10.1038/nature08199 Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol, 12, 247, 10.1038/ncb2024 Karube, 2005, Reduced expression of Dicer associated with poor prognosis in lung cancer patients, Cancer Sci, 96, 111, 10.1111/j.1349-7006.2005.00015.x Chiosea, 2007, Overexpression of Dicer in precursor lesions of lung adenocarcinoma, Cancer Res, 67, 2345, 10.1158/0008-5472.CAN-06-3533 Kumar, 2007, Impaired microRNA processing enhances cellular transformation and tumorigenesis, Nat Genet, 39, 673, 10.1038/ng2003 Melo, 2010, A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells, Cancer Cell, 18, 303, 10.1016/j.ccr.2010.09.007 Rotunno, 2010, Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival, Br J Cancer, 103, 1870, 10.1038/sj.bjc.6605976 Dalmay, 2006, MicroRNAs and the hallmarks of cancer, Oncogene, 25, 6170, 10.1038/sj.onc.1209911 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Johnson, 2005, RAS is regulated by the let-7 microRNA family, Cell, 120, 635, 10.1016/j.cell.2005.01.014 Johnson, 2007, The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res, 67, 7713, 10.1158/0008-5472.CAN-07-1083 Trang, 2010, Regression of murine lung tumors by the let-7 microRNA, Oncogene, 29, 1580, 10.1038/onc.2009.445 Calin, 2002, Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proc Natl Acad Sci U S A, 99, 15524, 10.1073/pnas.242606799 Cimmino, 2005, miR-15 and miR-16 induce apoptosis by targeting BCL2, Proc Natl Acad Sci U S A, 102, 13944, 10.1073/pnas.0506654102 Duan, 2010, MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells, Int J Cancer, 127, 313 Ghosh, 2010, Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis, J Clin Invest, 120, 4141, 10.1172/JCI42980 Yamakuchi, 2010, P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis, Proc Natl Acad Sci U S A, 107, 6334, 10.1073/pnas.0911082107 Cummins, 2006, Implications of micro-RNA profiling for cancer diagnosis, Oncogene, 25, 6220, 10.1038/sj.onc.1209914 Gregory, 2008, The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1, Nat Cell Biol, 10, 593, 10.1038/ncb1722 Olson, 2009, MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer, Genes Dev, 23, 2152, 10.1101/gad.1820109 Park, 2008, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, Genes Dev, 22, 894, 10.1101/gad.1640608 Burk, 2008, A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells, EMBO Rep, 9, 582, 10.1038/embor.2008.74 Bracken, 2008, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition, Cancer Res, 68, 7846, 10.1158/0008-5472.CAN-08-1942 Martello, 2010, A microRNA targeting dicer for metastasis control, Cell, 141, 1195, 10.1016/j.cell.2010.05.017 Volinia, 2010, Reprogramming of miRNA networks in cancer and leukemia, Genome Res, 20, 589, 10.1101/gr.098046.109 Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 Yu, 2008, MicroRNA signature predicts survival and relapse in lung cancer 4, Cancer Cell, 13, 48, 10.1016/j.ccr.2007.12.008 Landi, 2010, MicroRNA expression differentiates histology and predicts survival of lung cancer, Clin Cancer Res, 16, 430, 10.1158/1078-0432.CCR-09-1736 Voortman, 2010, MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma, Cancer Res, 70, 8288, 10.1158/0008-5472.CAN-10-1348 Hatley, 2010, Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21, Cancer Cell, 18, 282, 10.1016/j.ccr.2010.08.013 Ma, 2010, Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model, Nat Biotechnol, 28, 341, 10.1038/nbt.1618 Spizzo, 2010, miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells, Cell Death Differ, 17, 246, 10.1038/cdd.2009.117 Zhao, 2010, A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer, PloS ONE, 5, e13735, 10.1371/journal.pone.0013735 Klein, 2010, The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia, Cancer Cell, 17, 28, 10.1016/j.ccr.2009.11.019 Calin, 2005, A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, N Engl J Med, 353, 1793, 10.1056/NEJMoa050995 Rossi, 2010, MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival, Blood, 116, 945, 10.1182/blood-2010-01-263889 Stamatopoulos, 2009, MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification, Blood, 113, 5237, 10.1182/blood-2008-11-189407 Nicoloso, 2007, MicroRNAs in the pathogeny of chronic lymphocytic leukaemia, Br J Haematol, 139, 709, 10.1111/j.1365-2141.2007.06868.x Pekarsky, 2006, Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181, Cancer Res, 66, 11590, 10.1158/0008-5472.CAN-06-3613 Bichi, 2002, Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression, Proc Natl Acad Sci U S A, 99, 6955, 10.1073/pnas.102181599 Efanov, 2010, CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation, Leukemia, 24, 970, 10.1038/leu.2010.46 Schetter, 2008, MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma, JAMA, 299, 425, 10.1001/jama.299.4.425 Schetter, 2009, Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma, Clin Cancer Res, 15, 5878, 10.1158/1078-0432.CCR-09-0627 Michael, 2003, Reduced accumulation of specific microRNAs in colorectal neoplasia, Mol Cancer Res, 1, 882 Borralho, 2009, MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells, FEBS J, 276, 6689, 10.1111/j.1742-4658.2009.07383.x Valeri, 2010, Modulation of mismatch repair and genomic stability by miR-155, Proc Natl Acad Sci U S A, 107, 6982, 10.1073/pnas.1002472107 Wang, 2009, Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer, Dis Markers, 26, 27, 10.1155/2009/921907 Huang, 2010, The role of microRNAs in liver cancer progression, Br J Cancer, 104, 235, 10.1038/sj.bjc.6606010 Coulouarn, 2009, Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, Oncogene, 28, 3526, 10.1038/onc.2009.211 Gao, 2009, An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinoma, Carcinogenesis, 30, 2064, 10.1093/carcin/bgp283 Ji, 2009, MicroRNA expression, survival, and response to interferon in liver cancer, N Engl J Med, 361, 1437, 10.1056/NEJMoa0901282 Kota, 2009, Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model, Cell, 137, 1005, 10.1016/j.cell.2009.04.021 Lee, 2007, Expression profiling identifies microRNA signature in pancreatic cancer, Int J Cancer, 120, 1046, 10.1002/ijc.22394 Jiang, 2005, Real-time expression profiling of microRNA precursors in human cancer cell lines, Nucleic Acids Res, 33, 5394, 10.1093/nar/gki863 Bloomston, 2007, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA, 297, 1901, 10.1001/jama.297.17.1901 Dillhoff, 2008, MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival, J Gastrointest Surg, 12, 2171, 10.1007/s11605-008-0584-x Zhang, 2008, Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer, Proc Natl Acad Sci U S A, 105, 7004, 10.1073/pnas.0801615105 Iorio, 2007, MicroRNA signatures in human ovarian cancer, Cancer Res, 67, 8699, 10.1158/0008-5472.CAN-07-1936 Bendoraite, 2010, Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition, Gynecol Oncol, 116, 117, 10.1016/j.ygyno.2009.08.009 Hu, 2009, A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer, Gynecol Oncol, 114, 457, 10.1016/j.ygyno.2009.05.022 Yang, 2008, MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer, Cancer Res, 68, 10307, 10.1158/0008-5472.CAN-08-1954 Ratner, 2010, A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk, Cancer Res, 70, 6509, 10.1158/0008-5472.CAN-10-0689 Garzon, 2010, Targeting microRNAs in cancer: rationale, strategies and challenges, Nat Rev Drug Discov, 9, 775, 10.1038/nrd3179 Ebert, 2010, MicroRNA sponges: progress and possibilities, RNA, 16, 2043, 10.1261/rna.2414110 Valastyan, 2009, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis, Cell, 137, 1032, 10.1016/j.cell.2009.03.047 Ebert, 2010, Emerging roles for natural microRNA sponges, Curr Biol, 20, R858, 10.1016/j.cub.2010.08.052 Chen, 2010, Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy, Mol Ther, 18, 1650, 10.1038/mt.2010.136 Huynh, 2010, Efficient in vivo microRNA targeting of liver metastasis, Oncogene Lanford, 2010, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection, Science, 327, 198, 10.1126/science.1178178 Allen, 2010, Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics, Mol Cancer Ther, 9, 3126, 10.1158/1535-7163.MCT-10-0397 Nasser, 2008, Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1, J Biol Chem, 283, 33394, 10.1074/jbc.M804788200 Kong, 2010, MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer, J Biol Chem, 285, 17869, 10.1074/jbc.M110.101055 Giovannetti, 2010, MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity, Cancer Res, 70, 4528, 10.1158/0008-5472.CAN-09-4467 Ranade, 2010, MicroRNA 92a-2∗: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer, J Thorac Oncol, 5, 1273, 10.1097/JTO.0b013e3181dea6be Ferracin, 2010, MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia, Mol Cancer, 9, 123, 10.1186/1476-4598-9-123 Moussay, 2010, Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia, Mol Cancer, 9, 115, 10.1186/1476-4598-9-115 Blower, 2008, MicroRNAs modulate the chemosensitivity of tumor cells, Mol Cancer Ther, 7, 1, 10.1158/1535-7163.MCT-07-0573 Blower, 2007, MicroRNA expression profiles for the NCI-60 cancer cell panel, Mol Cancer Ther, 6, 1483, 10.1158/1535-7163.MCT-07-0009 Liu, 2010, mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities, Mol Cancer Ther, 9, 1080, 10.1158/1535-7163.MCT-09-0965 Liu, 2010, A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis, Eur J Cancer Hu, 2010, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J Clin Oncol, 28, 1721, 10.1200/JCO.2009.24.9342 Resnick, 2009, The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Gynecol Oncol, 112, 55, 10.1016/j.ygyno.2008.08.036 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A, 105, 10513, 10.1073/pnas.0804549105 Hunter, 2008, Detection of microRNA expression in human peripheral blood microvesicles, PLoS ONE, 3, e3694, 10.1371/journal.pone.0003694 Kroh, 2010, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, 50, 298, 10.1016/j.ymeth.2010.01.032